Stories Related to A Cancer Conundrum: Too Many Drug Trials, Too Few Patients

GINA KOLATA, NY Times: Health
Sat, 08/12/2017 - 11:47am

A Cancer Conundrum: Too Many Drug Trials, Too Few Patients

Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients.

PREV NEXT
Topics:  health   
RELATED ARTICLES
  • no title provided in feed
    Independent presidential candidate Robert F. Kennedy Jr. told The New York Times he experienced a series of health issues in recent years, including an abnormality that he said was caused by a worm that entered his brain and then died. More
  • no title provided in feed
    Americans' mental health issues are not identified and treated as readily as physical symptoms, especially among children - in part due to a shortage of clinicians. "We're looking for ways to integrate mental health into settings where children and families are every day," says Dr. More
  • no title provided in feed
    Mayor Donna Deegan speaks with CNN's Jake Tapper More
  • no title provided in feed
    Rep. Brad Wenstrup speaks with CNN's Jake Tapper More
  • no title provided in feed
    For some who see a therapist, just talking things through isn't enough. Drama therapy allows the patient to relive a moment or play out their biggest fears. More
  • no title provided in feed
    Sen. Mark Kelly joins The Lead More
PREV NEXT
BING NEWS:
  • FDA approves Amgen drug for tough-to-treat form of lung cancer
    Imdelltra, a bispecific antibody targeting a protein called DLL3, is cleared for use following chemotherapy in treating extensive-stage small cell lung cancer.
    05/17/2024 - 5:19 pm | View Link
  • New menopause drugs treat hot flashes, but women may face insurance hurdles
    Newer, nonhormonal drugs cost hundreds of dollars a month and may not be covered by insurance. Women who need them are left with the bill.
    05/17/2024 - 4:33 am | View Link
  • The Business Case For Expanding Diversity In Clinical Trials
    For drug developers, increasing representation in clinical trials is not just the right thing to do. It’s also good business.
    05/16/2024 - 12:00 am | View Link
  • UAB is already a national leader in clinical trials. Here is how it plans to extend the benefits to even more Alabamians.
    Over the past decade, the University of Alabama at Birmingham has become a national leader in clinical trials — studies examining the use of new treatments in people. Every drug, device and other ...
    05/15/2024 - 4:59 am | View Link
  • What’s behind the fight over high cancer drug dosages
    Cancer drug trials are structured to promote high doses, which then become routine patient care. In the face of evidence that thousands of patients become so ill that they skip doses or stop taking ...
    05/13/2024 - 10:05 am | View Link
  • More

 

PREV NEXT